Mequinol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Mequinol
Accession Number
DB09516
Type
Small Molecule
Groups
Approved
Description

Mequinol is a phenol used in various applications. It is used as an inhibitor for acrylic monomers and acrylonitirles, as a stabilizer for chlorinated hydrocarbons and ethyl cellulose, as an ultraviolet inhibitor, as a chemical intermediate in the manufacture of antioxidants, pharmaceuticals, plasticizers, and dyestuffs [1]. It is found as an active ingredient in topical drugs used for skin depigmentation indicated for the treatment of solar lentigines.

Structure
Thumb
Synonyms
  • 4-Methoxyphenol
External IDs
BMS-181158
Product Ingredients
Not Available
Approved Prescription Products
Not Available
Approved Generic Prescription Products
Not Available
Approved Over the Counter Products
Not Available
Unapproved/Other Products
Not Available
International/Other Brands
Not Available
Brand mixtures
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
SolagéSolutionTopicalGlaxosmithkline Inc2003-01-022014-03-04Canada
Categories
UNII
6HT8U7K3AM
CAS number
Not Available
Weight
Average: 124.1372
Monoisotopic: 124.0524295
Chemical Formula
C7H8O2
InChI Key
NWVVVBRKAWDGAB-UHFFFAOYSA-N
InChI
InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3
IUPAC Name
4-methoxyphenol
SMILES
COC1=CC=C(O)C=C1

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
AcetyldigitoxinAcetyldigitoxin may decrease the cardiotoxic activities of Mequinol.Approved
BevacizumabBevacizumab may increase the cardiotoxic activities of Mequinol.Approved, Investigational
CabazitaxelThe risk or severity of adverse effects can be increased when Cabazitaxel is combined with Mequinol.Approved
CyclophosphamideCyclophosphamide may increase the cardiotoxic activities of Mequinol.Approved, Investigational
DeslanosideDeslanoside may decrease the cardiotoxic activities of Mequinol.Approved
DigitoxinDigitoxin may decrease the cardiotoxic activities of Mequinol.Approved
DigoxinDigoxin may decrease the cardiotoxic activities of Mequinol.Approved
DocetaxelThe risk or severity of adverse effects can be increased when Docetaxel is combined with Mequinol.Approved, Investigational
OleandrinAnvirzel may decrease the cardiotoxic activities of Mequinol.Experimental
OuabainOuabain may decrease the cardiotoxic activities of Mequinol.Approved
PaclitaxelThe risk or severity of adverse effects can be increased when Paclitaxel is combined with Mequinol.Approved, Vet Approved
TrastuzumabTrastuzumab may increase the cardiotoxic activities of Mequinol.Approved, Investigational
Food Interactions
Not Available

References

Synthesis Reference
Not Available
General References
  1. TOXNET: 4-methoxyphenol [Link]
External Links
Human Metabolome Database
HMDB29696
ChemSpider
8665
ChEBI
69441
ChEMBL
CHEMBL544
HET
4KS
ATC Codes
D11AX06 — Mequinol
AHFS Codes
Not Available
PDB Entries
Not Available
FDA label
Not Available
MSDS
Not Available

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
SolutionTopical
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US6353029 No2000-08-242020-08-24Us

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility36.1 mg/mLALOGPS
logP1.31ALOGPS
logP1.51ChemAxon
logS-0.54ALOGPS
pKa (Strongest Acidic)9.94ChemAxon
pKa (Strongest Basic)-4.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area29.46 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity34.5 m3·mol-1ChemAxon
Polarizability12.76 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - EI-BGC-MSsplash10-00du-9300000000-7365fadaa1b55aee92c0
GC-MS Spectrum - EI-BGC-MSsplash10-0ab9-3900000000-b24cf2309ebe14f7ea37
GC-MS Spectrum - EI-BGC-MSsplash10-05gi-8900000000-22bed3d3611c3a5cd0d6
GC-MS Spectrum - EI-BGC-MSsplash10-0ab9-3900000000-b406ffca43dc64f80356
GC-MS Spectrum - EI-BGC-MSsplash10-05fr-3900000000-5f100d415313d60a9ba0
Predicted LC-MS/MS Spectrum - 10V, PositivePredicted LC-MS/MSsplash10-004i-0900000000-3d4bc54dec9d0d2bf71d
Predicted LC-MS/MS Spectrum - 20V, PositivePredicted LC-MS/MSsplash10-004i-1900000000-cd190cc17b12c804fb8d
Predicted LC-MS/MS Spectrum - 40V, PositivePredicted LC-MS/MSsplash10-0691-9200000000-f98954ef6d73d4d0fc19
Predicted LC-MS/MS Spectrum - 10V, NegativePredicted LC-MS/MSsplash10-00di-0900000000-3cb1894d95675088e7b2
Predicted LC-MS/MS Spectrum - 20V, NegativePredicted LC-MS/MSsplash10-00di-0900000000-125ba3d5d60e387415e5
Predicted LC-MS/MS Spectrum - 40V, NegativePredicted LC-MS/MSsplash10-0a4i-9600000000-c374964c5ebd2e35933e

Taxonomy

Description
This compound belongs to the class of organic compounds known as methoxyphenols. These are compounds containing a methoxy group attached to the benzene ring of a phenol moiety.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Phenols and derivatives
Direct Parent
Methoxyphenols
Alternative Parents
Methoxybenzenes / Anisoles / Alkyl aryl ethers / Hydrocarbon derivatives
Substituents
Methoxyphenol / Methoxybenzene / Phenol ether / Anisole / Alkyl aryl ether / Ether / Hydrocarbon derivative / Organooxygen compound / Aromatic homomonocyclic compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
organic molecular entity (CHEBI:69441 )
Drug created on November 30, 2015 12:10 / Updated on September 13, 2017 14:16